Annual report pursuant to Section 13 and 15(d)

SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details)

v3.23.1
SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details) - shares
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Conversion of Series B Preferred Stock [Member]    
Antidilutive securities, shares 292,990 235,774
Common Stock Options [Member]    
Antidilutive securities, shares 177,815 27,815
Common Stock Warrants [Member]    
Antidilutive securities, shares 323,543 37,083
Conversion of Convertible Notes [Member]    
Antidilutive securities, shares 64,126 75,625
Convertible Series A Preferred Stock [Member]    
Antidilutive securities, shares 216,577 108,231
Conversion of Debentures [Member]    
Antidilutive securities, shares   5,469